\(
\def\WIPO{World Intellectual Property Organisation}
\)
Generic drug entry prior to patent expiration : an FTC study / Federal Trade Commission.
2003
G 25 FTC. G
Available at WIPO Library
Items
Details
Title
Generic drug entry prior to patent expiration : an FTC study / Federal Trade Commission.
Description
xi, 68, 45 pages ; 23 cm.
ISBN
1575887452 alk. paper
9781575887456 alk. paper
9781575887456 alk. paper
Alternate Call Number
G 25 FTC. G
Note
Originally published: Washington, D.C. : Federal Trade Commission, 2002.
Formatted Contents Note
1. Introduction and background; 2. Outcomes of patent infringement lawsuits under the Hatch-Waxman amendments; 3. Settlements related to paragraph IV certifications; 4. Orange book patent listing practices and use of multiple 30-month stays; 5. 180-day marketing exclusivity under the Hatch-Waxman amendments; 6. FDA citizen petitions and generic drug applications.
Introduction and background
Outcomes of patent infringement lawsuits under the Hatch-Waxman amendments
Settlements related to Paragraph IV certifications
Orange book patent listing practices and use of multiple 30-month stays
180-day marketing exclusivity under the Hatch-Waxman amendments
FDA citizen petitions and generic drug applications.
Introduction and background
Outcomes of patent infringement lawsuits under the Hatch-Waxman amendments
Settlements related to Paragraph IV certifications
Orange book patent listing practices and use of multiple 30-month stays
180-day marketing exclusivity under the Hatch-Waxman amendments
FDA citizen petitions and generic drug applications.
Series
Hein's electronic documents reprint series ; title 9.
Published
Buffalo, N.Y. : W.S. Hein, 2003.
Language
English
Record Appears in
all